EAE/ASE 3D echocardiography image acquisition recommendations

January 03, 2012

Philadelphia, PA, January 3 - For the first time, a joint committee of the European Association for Echocardiography and the American Society of Echocardiography have issued recommendations on image acquisition using three-dimensional echocardiography (3DE). 'The EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography', are available in the January 2012 issue of the Journal of the American Society of Echocardiography (JASE), published by Elsevier.

The recommendations are a practical guide on how to acquire, analyze, and display the various cardiac structures using 3DE, and discuss the advantages and limitations of this technique. The document also describes current and potential clinical applications of 3DE and its specific strengths and weaknesses in each scenario. The same issue of JASE includes articles that explore novel applications of 3DE and illustrate the clinical relevance of this technique. These studies include, 'Geometric Assessment of Regional Left Ventricular Remodeling by 3D Echocardiographic Shape Analysis Correlates with Left Ventricular Function', by Ivan S. Salgo et al., 'Three dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation', by Alexandra Goncalves et al., and 'Automated Quantification of Mitral Inflow and Aortic Outflow Stroke Volumes By 3-D Real-Time Volume Color Flow Doppler Transthoracic Echocardiography: Comparison with Pulsed Wave Doppler and Cardiac Magnetic Resonance Imaging', by Paaladinesh Thavendiranathan et al.

3D echocardiography has been of considerable interest to researchers for more than 30 years, but improvements in imaging technology have made this technique more suitable for clinical use. Editor-in-Chief Dr. Alan S. Pearlman states, "I believe that real-time volumetric imaging using 3D echocardiography now provides a practical way to measure ventricular volumes and ejection fraction without making any assumptions about chamber geometry, and suspect that one day this imaging method will surpass current 2D echo imaging, just as 25 years ago 2D imaging supplanted M-mode echocardiography."

It is increasingly clear that 3D echo provides unique views in patients with valvular and congenital heart disorders, and the clinical use of this technique is likely to grow rapidly.
-end-
About the Journal of the American Society of Echocardiography

Journal of the American Society of Echocardiography (JASE) - official publication of the American Society of Echocardiography - brings physicians and sonographers the very latest clinical, scientific, legal, and economic information regarding the use of cardiac ultrasound. The journal's original, peer-reviewed articles cover conventional procedures as well as newer clinical techniques, such as transesophageal echocardiography, intraoperative echocardiography, and intravascular ultrasound.

JASE has a 2010 Impact Factor of 3.518 and ranks 30 of 114 journals in the Cardiac & Cardiovascular Systems, according to Thomson Reuters Journal Citation Reports®.

About the Editor-in-Chief

Alan S. Pearlman, MD, FASE, has been Editor-in-Chief of JASE since January 2008. He is a practicing non-invasive cardiologist at the University of Washington in Seattle, where he holds the rank of Professor of Medicine, and is a Past-President of ASE.

About the American Society of Echocardiography:

As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprising more than 15,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. Full text of ASE's guidelines is available at onlinejase.com. For more information about ASE, visit http://www.asecho.org or ASE's public information site, http://www.SeeMyHeart.org.

About Elsevier

Elsevier is a world-leading provider of scientific, technical, and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact

Francesca Costanzo
Elsevier
215-239-3249
f.costanzo@elsevier.com

Elsevier

Related Echocardiography Articles from Brightsurf:

CHOP researchers find MIS-C associated with myocardial injury
Using sensitive parameters to assess cardiac function, researchers at Children's Hospital of Philadelphia (CHOP) have found that cardiac involvement in multisystem inflammatory syndrome in children (MIS-C) differs from Kawasaki disease (KD) and is associated with myocardial injury.

New virtual screening tool eases, accelerates routine diagnosis of pulmonary hypertension
The COVID-19 pandemic has increasing numbers of doctors caring for patients virtually.

Special journal issue features Nemours heart specialists' best practices for children
The September issue of Progress in Pediatric Cardiology will exclusively feature articles by pediatric cardiologists at Nemours Children's Health System on echocardiography and other cardiac imaging techniques used in the care of children with cardiovascular disease.

Women, exercise and longevity
Women who can exercise vigorously are at significantly lower risk of dying from heart disease, cancer and other causes.

New analytical screening tools for the detection of cardiovascular disease
Presented in a study published in the journal Medical Image Analysis by Mariana Nogueira and Mathieu De Craene, first authors, within the framework of the CardioFunxion project, led by Bart Bijnens (ICREA) and Gemma Piella, members of the Physense and SiMBioSys research groups at BCN MedTech, experts in Machine Learning for clinical decision-making.

Pre-eclampsia may carry long-term heart risks for women
Pre-eclampsia is a potentially dangerous condition characterized by high blood pressure that arises in some pregnant women, but a review of published studies in Australasian Journal of Ultrasound in Medicine indicates that its effects on cardiovascular health can persist well after pregnancy.

Echocardiograms may help with patient selection for transcatheter mitral valve repair
Clinicians should use echocardiography, an ultrasound that shows the heart's structure and function, when determining whether patients with heart failure and a leaking heart valve are likely to benefit from valve repair, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

New training statement defines Level III echocardiography competencies for first time
A new advanced training statement from the American College of Cardiology, the American Heart Association and the American Society of Echocardiography defines the training requirements for performing advanced echocardiographic procedures, or 'Level III' training, for the first time.

Performance on exercise test predicts risk of death from cardiovascular disease and cancer
Performance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study presented today at EuroEcho-Imaging 2018.

Breast cancer patients who take heart drug with trastuzumab have less heart damage
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018.

Read More: Echocardiography News and Echocardiography Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.